From this data, we can see that Sanofi with its forward P/E of 19.73 is actually overvalued by 12% to this peer group average ...

The 12-hour Standing Committee on Policy and Strategic Priorities at city hall and its testy exchanges come two years into the current council's four-year mandate and illustrated the procedural ...